18 Mar 2020 13:56
LEI: 213800WRAP6W8VDL6B38
InnovaDerma PLC
("InnovaDerma" or the "Company")
Director/PDMR shareholding
InnovaDerma (LSE: IDP), a UK developer of life sciences, beauty and personal care products, announces that it was notified today, that Joseph Bayer, Executive Chairman of the Company, has purchased 19,000 Ordinary Shares of €0.10 each in the Company at a price of 35 pence per Ordinary Share (the "Acquisition") which will be held via his Australian Superannuation Fund which Mr Bayer controls. He now holds 160,000 Ordinary Shares in the Company via his Australian Superannuation Fund.
Following the Acquisition, Joseph Bayer has, through direct and indirect holdings, a total interest in the Company of 209,240 Ordinary Shares representing approximately 1.44% of the issued share capital of the Company.
This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.
Further enquiries
InnovaDerma Joe Bayer Kieran Callan c/o TB Cardew |
+61 (0)3 9863 8030 +44 (0)20 7930 0777 |
finnCap Ltd Geoff Nash/Kate Bannatyne Alice Lane/Manasa Patil - Corporate Broking |
+44 (0)207 220 0500 www.finncap.com |
TB Cardew Shan Shan Willenbrock/Tom Allison Olivia Rosser |
+ 44 (0)20 7930 0777 innovaDerma@tbcardew.com
|
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
1. | Details of the person discharging managerial responsibilities / person closely associated | |
a) | Name | Joseph Bayer |
2. | Reason for the Notification
| |
a) | Position/status | Executive Chairman |
b) | Initial notification/Amendment | Initial notification |
3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| |
a) | Name | InnovaDerma PLC
|
b) | LEI | 213800WRAP6W8VDL6B38
|
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| |
a) | Description of the Financial instrument, type of instrument | €0.10 each ("Ordinary Shares") |
Identification code | IDP GB00BT9PTW34
| |
b) | Nature of the transaction | Purchase of Ordinary Shares
|
c) | Price(s) and volume(s) | Volume -19,000 Ordinary Shares Price -35 pence per Ordinary Share
|
d) | Aggregated information: Aggregated volume Price |
See 4c) above
|
e) | Date of the transaction | 18 March 2020
|
f) | Place of the transaction | London Stock Exchange, Main Market
|